http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2061196-C
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-34 |
| filingDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce94361f5455b9ecd70a33e9dd33998 |
| publicationDate | 2002-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2061196-C |
| titleOfInvention | Acetylsalicyloyl l-carnitine and process for its preparation |
| abstract | Novel 3-(2-acetoxybenzoyloxy)-4-(trimethylammonio)-butyric acid betaine and its pharmaceutically acceptable salts are disclosed. The compounds are distinguished by high water solubility, minimum toxicity and good gastric tolerance vis-a-vis acetylsalicylic acid and can be prepared by acetylating the corresponding salicylic acid ester of the carnitine. |
| priorityDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.